Industry benchmarking report on publicly traded CBD companies
Summary
The passage provides market sizing and retail footprint data for cannabis‑derived companies but contains no specific allegations, financial flows, or links to high‑level officials. It offers limited i Lists CEOs and executives of several CBD firms (e.g., Brian Athaide of TGOD, James Hamilton of NEPT) Notes an agreement between Organigram and 1812 Hemp for hemp research. Provides retail store count
This document is from the House Oversight Committee Releases.
View Source CollectionTags
Related Documents (6)
Ackrell Capital Report on Cannabis Debt Financing
The document is a generic industry analysis of cannabis financing without any specific allegations, names, transactions, or controversial actions involving powerful actors. It offers no actionable inv Direct lenders are filling a financing gap for cannabis companies due to lack of bank loans. Debt costs for cannabis firms are 200‑500 basis points higher than other sectors. Valuations in the cannab
Ackrell Capital Cannabis Industry Segmentation Report – Concentrates Sales and Extraction Methods (Q3 2017)
The passage provides market data on cannabis concentrate sales and technical details on extraction methods. It contains no references to high‑profile individuals, government agencies, financial flows, Q3 2017 concentrate sales split: Live resin (6%), B Oils (18%), Shatter (16%), Vape oil (17%), Wax ( Two extraction categories: solvent‑based (hydrocarbon, CO₂, ethanol) and solvent‑free (filters, ic
Ackrell Capital Cannabis Investment Report (Dec 2017) outlines market size and federal‑state regulatory landscape
The passage provides general industry data and describes federal policy context but offers no concrete names, transactions, dates, or actionable leads linking high‑level officials or agencies to misco U.S. state‑legal cannabis market estimated at $8.0 billion in 2017. Breakdown by state: California $3.2 B, Colorado $1.5 B, Washington $929 M, Oregon $470 M, other stat Federal law still prohibits al
Industry overview of Curaleaf, CV Sciences, Elixinol, and Green Thumb Industries CBD product lines (Feb 2019)
The passage provides a market‑focused summary of several publicly traded cannabis/MSO companies and their product expansions. It contains no specific allegations, financial flows, or connections to hi Curaleaf launched a CBD line sold in 47 states, targeting pharmacy chains and grocery stores. Curaleaf reported ~$45 M revenue for FY9M18 with 247% YoY growth and 57% gross margin. CV Sciences’ PlusC
Directory of Private Cannabis Companies Featured in House Oversight Report
The passage lists several private cannabis producers and their products without mentioning any high‑profile individuals, government agencies, financial transactions, or alleged misconduct. It offers n Level Blends – California cannabis concentrate producer. Lunchbox Alchemy – Oregon cannabis edibles and concentrates maker. LivWell Enlightened Health – Colorado/ Oregon dispensary operator and culti
Cannabis Industry Company Listings in 2017 Investment Report
The passage lists several small cannabis businesses and a research firm with no mention of high‑profile officials, financial misconduct, or controversial actions. It provides no actionable leads, date Identifies Auntie Dolores, a cannabis edibles producer in Oakland, CA. Lists BAS Research, a cannabis oil extraction and manufacturing firm in Berkeley, CA. Mentions Baker Technologies, a CRM platfor
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.